Effect of TEAS on the Incidence Rate of SIRS in Patients Undergoing Abdominal Surgery
NCT ID: NCT02193477
Last Updated: 2015-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
105 participants
INTERVENTIONAL
2014-07-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Pancreatectomy
NCT06541561
Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
NCT06341270
Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy
NCT06406244
TEAS to Improve Outcome During Emergence From General Anesthesia After Robotic Surgery
NCT02323958
Acupuncture-assisted-anesthesia to Improve Postoperative Outcome After Digestive Surgery in Elderly Patients
NCT02239159
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
TEAS group receiving TEAS before general anesthesia induction , 1th day and 2nd day after surgery. TEAS was given through electrodes attached to specific acupoints. The time for TEAS was 30min.
Sham TEAS group receiving sham TEAS before general anesthesia induction , 1th day and 2nd day after surgery. Sham TEAS was given through electrodes attached to non-acupoints. The time for sham TEAS was also 30min.
Control group were given no TEAS. Incidence rates of SIRS in each group were compared .Venous blood samples from all groups(control group , TEAS group and sham TEAS group) were collected before general anesthesia induction,1th day and 3rd day after surgery. Inflammatory cytokines index including interleukin-6,interleukin-10,Tumor Necrosis Factor- alpha(TNF-α),Interferon-γ(IFN-γ),Monocyte Chemotactic Protein 1(MCP-1),IgG,IgM were measured.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Patients were given no TEAS.
No interventions assigned to this group
TEAS Treatment
Patients were given 30min of TEAS before general anesthesia induction, 1th day and 2nd day after surgery.
TEAS
Electric stimulation was given through electrode attached to specific acupoints for 30mins before general anesthesia induction,1th day and 2nd day after surgery.
Sham TEAS
Patients were given 30min of sham TEAS before general anesthesia induction,1th day and 2nd day after surgery.
Sham TEAS
Electric stimulation was given through electrode attached to non-acupoints for 30mins before general anesthesia induction,1th day and 2nd day after surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TEAS
Electric stimulation was given through electrode attached to specific acupoints for 30mins before general anesthesia induction,1th day and 2nd day after surgery.
Sham TEAS
Electric stimulation was given through electrode attached to non-acupoints for 30mins before general anesthesia induction,1th day and 2nd day after surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA 1-2
* Scheduled for radical surgery for gastric cancer under general anesthesia；
* Informed consented
Exclusion Criteria
* Patients with severe hypertension or cardiac dysfunction；
* Patients with severe pulmonary disease
* Patients with hemoglobin\<90g/L
30 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Air Force Military Medical University, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
QiangWang,MD
associate professor,PhD advisor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qiang Wang, MD
Role: STUDY_CHAIR
Air Force Military Medical University, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fourth Military Medical University
Xi’an, Shanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Gjian
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.